" class="no-js "lang="en-US"> Cari-Anne Quinn - Medtech Alert
Friday, August 01, 2025

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
Cari-Anne Quinn

Cari-Anne Quinn

About Cari-Anne Quinn

I’m passionate about nurturing businesses in the health life sciences sector, helping them to achieve growth and sustainability. I have over 25 years’ experience of economic development, which includes considerable international exposure. For the last 20 years, my experience has been in the life sciences sector, delivering innovation, business growth and internationalisation.

Related Story

Health Apps

 New Digital Resource Launched to Support Health

New Digital Resource Launched to Support Health, Social Care and Industry Innovation

July 16 2021

Achieving Innovation is a new resource developed by Life Sciences Hub Wales to inform and […]